Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Jan;63(1):108–113. doi: 10.1172/JCI109263

A Study of Human Leukocyte D Locus Related Antigens in Graves' Disease

Nadir R Farid 1,2, Laura Sampson 1,2, Elke P Noel 1,2, John M Barnard 1,2, Robert Mandeville 1,2, Bodil Larsen 1,2, William H Marshall 1,2, Nicholas D Carter 1,2
PMCID: PMC371924  PMID: 105012

Abstract

An association between Graves' disease and the human leukocyte antigen (HLA) system has previously been reported. The disease was more strongly associated with the HLA D locus antigen Dw3 than with HLA B8. Products of the HLA D locus are determined by the interaction of test cells with standard typing lymphocytes, a technically difficult procedure. Recently, it has been possible to type serologically for D locus related (DRw) specificities on peripheral bone marrow-derived (B) lymphocytes. Blood B lymphocytes from 50 unrelated controls and 41 patients with Graves' disease were typed for seven HLA DRw specificities. 28 patients with Graves' disease (68%) were positive for DRw3, in contrast to 14 controls (28%); whereas only 21 patients (50%) were HLA B8 positive, compared with 13 (26%) controls. Thus, positivity for DRw3 afforded a relative risk for Graves' disease of 5.5, whereas that for HLA B8 amounted to 3.0. Additionally, a family with multiple cases of Graves' disease in which the disease was previously shown to be inherited with the haplotype, was linked to DRw2, which suggests that the susceptibility to the disease was inherited in association with that antigen. Two HLA B/glyoxalase recombination events were observed in this family; in both instances HLA DRw followed HLA B. This study thus demonstrates that the disease susceptibility gene for Graves' disease is in strong linkage disequilibrium with DRw3; however, it may be associated with other DRw specificities and inherited within family units in association with them.

Full text

PDF
112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armerding D., Katz D. H. Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. J Exp Med. 1974 Jul 1;140(1):19–37. doi: 10.1084/jem.140.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bach F. H., Widmer M. B., Bach M. L., Klein J. Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med. 1972 Dec 1;136(6):1430–1444. doi: 10.1084/jem.136.6.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bech K., Lumholtz B., Nerup J., Thomsen M., Platz P., Ryder L. P., Svejgaard A., Siersbaek-Nielsen K., Hansen J. M., Larsen J. H. HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 1977 Nov;86(3):510–516. doi: 10.1530/acta.0.0860510. [DOI] [PubMed] [Google Scholar]
  4. Bechtol K. B., McDevitt H. O. Antibody response of C3H in equilibrium (CKB X CWB)F1 tetraparental mice to poly-L(Tyr,Glu)-poly-D,L-Ala-poly-L-Lys immunization. J Exp Med. 1976 Jul 1;144(1):123–144. doi: 10.1084/jem.144.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 1972 Jan 21;175(4019):273–279. doi: 10.1126/science.175.4019.273. [DOI] [PubMed] [Google Scholar]
  6. Bodmer J., Pickbourne P., Bodmer W., Batchelor R., Dewar P., Dick H., Entwistle C., Festenstein H., Gelsthorpe K., Joysey V. Serological identification of Ia antigens: report of a British region Ia workshop. Tissue Antigens. 1976 Nov;8(5):359–371. doi: 10.1111/j.1399-0039.1976.tb00588.x. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl. 1968;97:9–29. [PubMed] [Google Scholar]
  8. Cullen S. E., David C. S., Cone J. L., Sachs D. H. Evidence for more than one Ia antigenic specificity on molecules determined by the I-A subregion of the mouse major histocompatibility complex. J Immunol. 1976 Feb;116(2):549–553. [PubMed] [Google Scholar]
  9. Farid N. R., Barnard J. M., Marshall W. H. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens. 1976 Sep;8(3):181–189. doi: 10.1111/j.1399-0039.1976.tb00567.x. [DOI] [PubMed] [Google Scholar]
  10. Farid N. R., Barnard J. M., Marshall W. H., Woolfrey I., O'Driscoll R. F. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA. J Clin Endocrinol Metab. 1977 Dec;45(6):1165–1172. doi: 10.1210/jcem-45-6-1165. [DOI] [PubMed] [Google Scholar]
  11. Grumet F. C., Payne R. O., Konishi J., Kriss J. P. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab. 1974 Dec;39(6):1115–1119. doi: 10.1210/jcem-39-6-1115. [DOI] [PubMed] [Google Scholar]
  12. Irvine W. J., Gray R. S., Morris P. J., Ting A. Correlation of HLA and thyroid antibodies with clinical course of thyrotoxicosis treated with antithyroid drugs. Lancet. 1977 Oct 29;2(8044):898–900. doi: 10.1016/s0140-6736(77)90833-9. [DOI] [PubMed] [Google Scholar]
  13. Lozner E. C., Sachs D. H., Shearer G. M., Terry W. D. B-cell alloantigens determined by the H-2 linked Ir region are associated with mixed lymphocyte culture stimulation. Science. 1974 Feb 22;183(4126):757–759. doi: 10.1126/science.183.4126.757. [DOI] [PubMed] [Google Scholar]
  14. Mann D. L., Abelson L., Harris S., Amos D. B. Second genetic locus in the HLA region for human B-cell alloantigens. Nature. 1976 Jan 15;259(5539):145–146. doi: 10.1038/259145a0. [DOI] [PubMed] [Google Scholar]
  15. McDevitt H. O., Deak B. D., Shreffler D. C., Klein J., Stimpfling J. H., Snell G. D. Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med. 1972 Jun 1;135(6):1259–1278. doi: 10.1084/jem.135.6.1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McDevitt H. O., Delovitch T. L., Press J. L., Murphy D. B. Genetic and functional analysis of the Ia antigens: their possible role in regulating the immune response. Transplant Rev. 1976;30:197–235. doi: 10.1111/j.1600-065x.1976.tb00221.x. [DOI] [PubMed] [Google Scholar]
  17. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  18. Parr C. W., Bagster I. A., Welch S. G. Human red cell glyoxalase I polymorphism. Biochem Genet. 1977 Feb;15(1-2):109–113. doi: 10.1007/BF00484553. [DOI] [PubMed] [Google Scholar]
  19. Sasazuki T., McDevitt H. O., Grumet F. C. The association between genes in the major histocompatibility complex and disease susceptibility,. Annu Rev Med. 1977;28:425–452. doi: 10.1146/annurev.me.28.020177.002233. [DOI] [PubMed] [Google Scholar]
  20. Svejgaard A., Jersild C., Nielsen L. S., Bodmer W. F. HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens. 1974;4(2):95–105. doi: 10.1111/j.1399-0039.1974.tb00230.x. [DOI] [PubMed] [Google Scholar]
  21. Taussig M. J., Munro A. J., Campbell R., David C. S., Staines N. A. Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers. J Exp Med. 1975 Sep 1;142(3):694–700. doi: 10.1084/jem.142.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. van Rood J. J., van Leeuwen A., Keuning J. J., Termijtelen A. Evidence for two series of B-cell antigens in man and their comparison with HLA-D. Scand J Immunol. 1977;6(5):373–384. doi: 10.1111/j.1365-3083.1977.tb02092.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES